Proteins, the molecular workhorses of life, have been at the heart of countless scientific breakthroughs and industrial applications. However, their inherent limitations, shaped by millions of years of evolution, often hinder their utility in modern contexts …

The biopharmaceutical industry stands at the forefront of modern medicine, offering life-saving treatments such as antibodies, vaccines, and cell therapeutics. Central to the production of these advanced therapies are mammalian cell lines, with Chinese Hamster Ovary (CHO) cells being the workhorse of choice.

Imagine a future where the pharmaceuticals we rely on every day are derived from renewable agricultural and forestry waste rather than non-renewable petroleum resources. This vision represents a transformative shift in the pharmaceutical industry towards sustainability and circular economy. The advent of green and bio-based pharmaceuticals heralds a new era where innovative approaches in green chemistry and biotechnology can produce therapeutic agents and with a significantly reduced ecological footprint. This holistic strategy aligns with the increasing global demand for sustainable solutions, setting the stage for a future rich in renewable medicines and adjuvants.

Welcome, curious innovators of digestive health! If you’re tired of the same old gut health solutions, it’s time to turn your attention to a tiny yet mighty game-changer: Milk Extracellular Vesicles (mEVs). These microscopic marvels are poised to revolutionize the way we approach gut health, and we’re here to tell you why.

Greetings, Life Science Jedis on a quest to unravel the mysteries of the protein galaxy! In your journey through the biochemical universe, traditional techniques often leave you stranded on the dark side of insufficient data, akin to facing the formidable Death Star . But fear not, for the Austrian Centre of Industrial Biotechnology (acib) has harnessed a tool that would impress even Master Yoda: Hydrogen-Deuterium Exchange coupled to Mass Spectrometry (HDX-MS).

The quest for healthier lifestyles has driven substantial interest in natural compounds with proven health benefits. Among these, phytosterols stand out as a powerful group of substances with a plethora of positive effects on human and animal health.

Have you ever heard of the gut microbiome? It’s a fancy way of saying the trillions of microorganisms that live inside your intestines. These aren’t unwanted guests, but a complex ecosystem known as the gut microbiome. These microscopic marvels play a surprisingly significant role in your overall health, influencing everything from digestion and immunity to mood and even weight management.

Our world craves flexibility. From the bounce in our athletic shoes to the stretch in our favorite clothing, elastic materials play a vital role in our daily lives. However, there’s a dark side to this convenience: traditional elastic materials often rely on synthetic polymers derived from fossil fuels. These materials contribute to plastic pollution and a growing environmental crisis.

The Bio-based Industries Consortium (BIC) in partnership with the European Union has announced an open call for proposals under the Circular Bio-based Europe Joint Undertaking (CBE JU). It funds research and innovation projects that advance circular bio-based industries in Europe under the EU’s Horizon Europe programme. The 2024 call for proposals is open for submission until 18 September 2024 at 17:00 CET.

In the midst of the COVID-19 pandemic, the development and deployment of mRNA vaccines have been hailed as a triumph of modern medicine. These groundbreaking vaccines offer unprecedented levels of efficacy against the virus, paving the way for a return to normalcy. However, concerns have emerged regarding the safety profile of mRNA vaccines, particularly with regards to the risk of adverse effects such as myocarditis. In this blog, we delve into an innovative approach to enhance the safety and efficacy of mRNA vaccines: the incorporation of vasoconstrictors during vaccine preparation.

In the vast landscape of pharmaceuticals, plant-derived compounds, also called alkaloids, have long held a significant place. Many of them are first choice medicines to treat cancer, pain, malaria, and dementia. Production of these essential compounds by large still relies on field-grown plant material and chemical extraction. The lack of alternative production platforms makes supply chains of alkaloid-based medication vulnerable and dependent on environmental and socio-economic factors. To overcome current limitations, acib is in the forefront to develop a scalable, bioreactor-based technology to produce high-value plant alkaloids through a plant cell-based technology. Therefore, we are looking for partners to join our forces to revolutionize the production of plant alkaloids.